Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-130745
Filing Date
2018-04-25
Accepted
2018-04-25 12:33:05
Documents
23
Period of Report
2018-06-05
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d562596ddef14a.htm DEF 14A 1737459
2 GRAPHIC g562596g11r84.jpg GRAPHIC 33180
3 GRAPHIC g562596g14e01.jpg GRAPHIC 25324
4 GRAPHIC g562596g21r93.jpg GRAPHIC 24690
5 GRAPHIC g562596g22q87.jpg GRAPHIC 281698
6 GRAPHIC g562596g23k78.jpg GRAPHIC 31267
7 GRAPHIC g562596g31c02.jpg GRAPHIC 43551
8 GRAPHIC g562596g32v27.jpg GRAPHIC 29159
9 GRAPHIC g562596g36v34.jpg GRAPHIC 31005
10 GRAPHIC g562596g52m79.jpg GRAPHIC 36363
11 GRAPHIC g562596g54q16.jpg GRAPHIC 42364
12 GRAPHIC g562596g58w78.jpg GRAPHIC 29573
13 GRAPHIC g562596g62p97.jpg GRAPHIC 35054
14 GRAPHIC g562596g69x47.jpg GRAPHIC 35138
15 GRAPHIC g562596g70w96.jpg GRAPHIC 33096
16 GRAPHIC g562596g73h83.jpg GRAPHIC 41063
17 GRAPHIC g562596g91e40.jpg GRAPHIC 31890
18 GRAPHIC g562596g91r20.jpg GRAPHIC 30133
19 GRAPHIC g562596g92v35.jpg GRAPHIC 28823
20 GRAPHIC g562596g93v53.jpg GRAPHIC 28998
21 GRAPHIC g562596g95v27.jpg GRAPHIC 34041
22 GRAPHIC g562596g96t45.jpg GRAPHIC 61276
23 GRAPHIC g562596g97t06.jpg GRAPHIC 29592
  Complete submission text file 0001193125-18-130745.txt   3102039
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-16174 | Film No.: 18773507
SIC: 2834 Pharmaceutical Preparations